Cassava Sciences has faced a lot of scrutiny, with key figures resigning and the company settling an SEC penalty. Read what ...

Cassava Sciences' stock is highly shorted, with potential reward tied to the upcoming Phase 3 trial results for simufilam.

Top-line Data for RETHINK-ALZ 52-week Phase 3 trial Expected Before the End of 2024$149.0 Million in Cash and Cash Equivalents at September 30, ...

Cassava has been identified as a major cash crop with many derivatives for growing Nigeria’s economy and expanding the gross domestic product if prioritised by the government. The Managing ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Bearish flow noted in Cassava Sciences (SAVA) with 2,978 puts trading, or 1.3x expected. Most active are Nov-24 27 puts and Dec-24 10 puts, with total volume in those strikes near 1,500 contracts.

Data is not available at this time. Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is ...

KINGSTON, Jamaica — The 48-hour curfew that was imposed in sections of Cassava Piece, Kingston 8 on Thursday has been extended for another 48 hours. The extended curfew will now end at 6:00 am ...

Cassava Sciences and two former executives will pay more than $40 million to settle charges related to misleading statements made about a clinical trial for the company's purported therapeutic ...

Friday's Top 5 Trending Stocks: What's The Scoop On GameStop, SoFi, Tesla? GameStop, SoFi, Tesla, Cassava Sciences and Anavex Life Sciences are the top five trending stocks on Stocktwits Friday.

In this article, we are going to take a look at where Cassava Sciences, Inc. (NASDAQ:SAVA) stands against other stocks discussed by Jim Cramer during the latest lightning round. On Tuesday ...